Published in J Exp Med on December 20, 2004
Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol (2005) 2.08
Mast cells and inflammation. Biochim Biophys Acta (2010) 1.91
Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci U S A (2008) 1.42
Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration. Clin Dev Immunol (2008) 1.19
Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation. Mol Cancer Ther (2009) 1.12
Animal models of multiple sclerosis for the development and validation of novel therapies - potential and limitations. J Neurol (2008) 1.08
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis. Metabolomics (2011) 1.06
Role of microglia in neuronal degeneration and regeneration. Semin Immunopathol (2009) 1.06
Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters. Int J Mol Sci (2012) 1.02
Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis. BMC Bioinformatics (2011) 1.01
Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells. Br J Pharmacol (2008) 1.01
Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. J Nutr (2010) 0.99
Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease. Epilepsia (2012) 0.98
The influence of nutritional factors on the prognosis of multiple sclerosis. Nat Rev Neurol (2012) 0.97
Axon growth inhibition by RhoA/ROCK in the central nervous system. Front Neurosci (2014) 0.97
Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv Nutr (2015) 0.93
A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats. Am J Pathol (2011) 0.91
The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS One (2007) 0.89
Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis. ASN Neuro (2013) 0.88
Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types. J Neuroinflammation (2011) 0.88
Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents. Clin Exp Immunol (2008) 0.87
Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis. Ther Clin Risk Manag (2014) 0.85
Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activity. Mol Biol Rep (2013) 0.83
Luteolin as a therapeutic option for multiple sclerosis. J Neuroinflammation (2009) 0.83
Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion. Anal Bioanal Chem (2012) 0.80
HESA-A Exerts Its Cytoprotective Effects through Scavenging of Free Radicals: An in Vitro Study. Iran J Med Sci (2012) 0.79
Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta. J Neuroinflammation (2009) 0.79
Apigenin: is it a pro- or anti-inflammatory agent? Am J Pathol (2006) 0.78
Effects of coenzyme Q10 on the ratio of TH1/TH2 in experimental autoimmune encephalomyelitis model of multiple sclerosis in C57BL/6. Iran Biomed J (2014) 0.76
Effects of Luteolin on Liver, Kidney and Brain in Pentylentetrazol-Induced Seizures: Involvement of Metalloproteinases and NOS Activities. Balkan Med J (2012) 0.76
Flavones: From Biosynthesis to Health Benefits. Plants (Basel) (2016) 0.76
Absence of system xc(-) on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis. J Neuroinflammation (2017) 0.75
Expression of RhoA by inflammatory macrophages and T cells in rat experimental autoimmune neuritis. J Cell Mol Med (2007) 0.75
Luteolin reduces migration of human glioblastoma cell lines via inhibition of the p-IGF-1R/PI3K/AKT/mTOR signaling pathway. Oncol Lett (2017) 0.75
Rho GTPases in cell biology. Nature (2002) 22.81
Rho and Rac take center stage. Cell (2004) 10.64
The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev (2000) 8.92
Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol (1999) 6.01
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience (1990) 4.52
Redox-dependent downregulation of Rho by Rac. Nat Cell Biol (2003) 4.46
RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol (2001) 3.79
The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol (2004) 2.40
Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol (1999) 2.16
Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med (1996) 1.98
Calcium signaling regulates translocation and activation of Rac. J Biol Chem (2003) 1.94
Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol (2002) 1.44
Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis. FASEB J (2003) 1.38
Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol (2002) 1.35
Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J Immunol (2002) 1.26
Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett (1998) 1.23
RhoA activation promotes transendothelial migration of monocytes via ROCK. J Leukoc Biol (2003) 1.16
Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J (2001) 1.15
Health effects and bioavailability of dietary flavonols. Free Radic Res (1999) 1.11
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. J Neuroimmunol (2004) 1.09
Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol (1995) 1.09
CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A (2002) 0.97
A hydroxyl group of flavonoids affects oral anti-inflammatory activity and inhibition of systemic tumor necrosis factor-alpha production. Biosci Biotechnol Biochem (2004) 0.93
Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochem Pharmacol (2003) 0.93
How do statins control neuroinflammation? Inflamm Res (2003) 0.82
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science (2011) 3.52
The macrophage scavenger receptor CD163. Immunobiology (2005) 2.44
Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol (2008) 2.29
The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood (2008) 1.96
The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol (2005) 1.76
Macrophages and neurodegeneration. Brain Res Brain Res Rev (2005) 1.64
Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J (2007) 1.63
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation (2013) 1.59
Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J Neurochem (2006) 1.43
Hydrogels as extracellular matrices for skeletal tissue engineering: state-of-the-art and novel application in organ printing. Tissue Eng (2007) 1.42
Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta (2010) 1.40
The effect of photopolymerization on stem cells embedded in hydrogels. Biomaterials (2008) 1.39
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain (2008) 1.38
Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol (2002) 1.35
Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J (2006) 1.34
Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion (2010) 1.34
The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol (2003) 1.32
Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol (2006) 1.30
CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia (2005) 1.30
Three-dimensional fiber deposition of cell-laden, viable, patterned constructs for bone tissue printing. Tissue Eng Part A (2008) 1.29
Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal (2011) 1.29
Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology (2007) 1.28
Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J Immunol (2002) 1.26
Organ printing: the future of bone regeneration? Trends Biotechnol (2011) 1.26
The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production. Immunobiology (2006) 1.25
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. Acta Neuropathol (2012) 1.22
Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J Cereb Blood Flow Metab (2003) 1.21
The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol (2007) 1.20
Use of fluorochrome labels in in vivo bone tissue engineering research. Tissue Eng Part B Rev (2010) 1.17
Retinoic acid induces blood-brain barrier development. J Neurosci (2013) 1.17
RhoA activation promotes transendothelial migration of monocytes via ROCK. J Leukoc Biol (2003) 1.16
Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions. Glia (2010) 1.15
Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation. Epilepsia (2012) 1.15
Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis (2005) 1.14
Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J Neuroimmunol (2003) 1.14
Biofabrication of osteochondral tissue equivalents by printing topologically defined, cell-laden hydrogel scaffolds. Tissue Eng Part C Methods (2011) 1.10
Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflammation (2012) 1.09
MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO. J Cereb Blood Flow Metab (2007) 1.07
MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis. J Neurosci (2013) 1.07
Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells. Ultrasound Med Biol (2009) 1.07
Systemic inflammation and fracture healing. J Leukoc Biol (2011) 1.06
SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function. Am J Physiol Heart Circ Physiol (2007) 1.05
Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev (2007) 1.04
Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells. Biomaterials (2011) 1.03
Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes. J Neuropathol Exp Neurol (2005) 1.03
Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-dependent pathways. Mol Cell Biol (2005) 1.02
Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol Dis (2006) 1.02
In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology. J Neuroimmunol (2005) 1.02
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic Biol Med (2010) 1.00
The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem Pharmacol (2004) 1.00
The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis. J Neuroimmunol (2002) 0.99
Functions of lipid raft membrane microdomains at the blood-brain barrier. J Mol Med (Berl) (2009) 0.99
A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model. Tissue Eng Part A (2012) 0.99
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Mol Immunol (2012) 0.98
CXC-chemokines KC and macrophage inflammatory protein-2 (MIP-2) synergistically induce leukocyte recruitment to the central nervous system in rats. Immunol Lett (2003) 0.97
Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol (2008) 0.97
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation. J Neuroinflammation (2014) 0.97
Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function. J Mol Med (Berl) (2003) 0.96
The role of endothelial progenitor cells in prevascularized bone tissue engineering: development of heterogeneous constructs. Tissue Eng Part A (2010) 0.96
Luciferase labeling for multipotent stromal cell tracking in spinal fusion versus ectopic bone tissue engineering in mice and rats. Tissue Eng Part A (2010) 0.95
Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier. J Immunol (2008) 0.95
Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. FASEB J (2012) 0.95
Hypoxia impedes hypertrophic chondrogenesis of human multipotent stromal cells. Tissue Eng Part A (2012) 0.95
Tumor infiltrating macrophages reduce development of peritoneal colorectal carcinoma metastases. Cancer Lett (2008) 0.95
Photopolymerized thermosensitive hydrogels: synthesis, degradation, and cytocompatibility. Biomacromolecules (2008) 0.95
Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol (2012) 0.95
Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE. J Neuroimmunol (2003) 0.94
Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis. Glia (2011) 0.94
Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochem Pharmacol (2003) 0.93
Sustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats. PLoS One (2013) 0.92
C1 inhibitor treatment improves host defense in pneumococcal meningitis in rats and mice. J Infect Dis (2007) 0.92
Heparan sulfate proteoglycans modulate monocyte migration across cerebral endothelium. J Neuropathol Exp Neurol (2003) 0.92
In vivo bioluminescence imaging study to monitor ectopic bone formation by luciferase gene marked mesenchymal stem cells. J Orthop Res (2008) 0.92
Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases. Arch Toxicol (2014) 0.92